Skip to main content

The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Testicular cancer in Australia statistics

Explore statistics on testicular cancer, including the number of new cases, deaths, survival rates, and overall prevalence.

964 Estimated number of new cases of testicular cancer diagnosed in 2022
1.1% Estimated % of all new male cases of cancer diagnosed in 2022
31 Estimated number of deaths from testicular cancer in 2022
0.11% Estimated % of male deaths from cancer in 2022
97% Chance of surviving at least 5 years (2014–2018)
4,058 People living with testicular cancer at the end of 2017 (diagnosed in the 5 year period 2013 to 2017)

The following material has been sourced from the Australian Institute of Health and Welfare

Testicular cancer incorporates ICD-10 cancer code C62 (Malignant neoplasm of testis).

New cases

In 2018, there were 898 new cases of testicular cancer diagnosed in Australia. In 2022, it is estimated that 964 new cases of testicular cancer will be diagnosed in Australia. In 2022, it is estimated that a male has a 1 in 181 (or 0.55%) risk of being diagnosed with testicular cancer by the age of 85.

Figure 1. Estimated cancer incidence in Australia among males, 2022
Figure 1. Estimated cancer incidence in Australia among males, 2022

Notes 

In 2018, the age-standardised incidence rate was 7.4 cases per 100,000 males. In 2022, it is estimated that the age-standardised incidence rate will be 7.8 cases per 100,000 males. The incidence rate for testicular cancer is expected to be highest for those aged 30–34 years, and then decrease.

Figure 2. Age-standardised incidence rates for testicular cancer, 1982 to 2018
Figure 2. Age-standardised incidence rates for testicular cancer, 1982 to 2018

Notes

The number of new cases of testicular cancer diagnosed increased from 321 in 1982 to 898 in 2018. Over the same period, the age-standardised incidence rate increased from 4.2 cases per 100,000 males in 1982 to 7.4 cases per 100,000 in 2018.

Deaths 

In 2020, there were 19 deaths from testicular cancer in Australia. In 2022, it is estimated that there will be 31 deaths. In 2022, it is estimated that a male had a 1 in 5,335 (or 0.02%) risk of dying from testicular cancer by the age of 85.

Figure 3. Estimated cancer mortality in Australia among males, 2022
Figure 3. Estimated cancer mortality in Australia among males, 2022

Notes 

In 2020, the age-standardised mortality rate was 0.2 deaths per 100,000 males. In 2022, it is estimated that the age-standardised mortality rate will be 0.2 deaths per 100,000 males. The mortality rate for testicular cancer is expected to vary across age groups.

Figure 4. Age-standardised mortality rates for testicular cancer, 1982 to 2020
Figure 4. Age-standardised mortality rates for testicular cancer, 1982 to 2020

Notes

The number of deaths from testicular cancer decreased from 34 in 1982 to 19 in 2020. Over the same period, the age-standardised mortality rate remained similar from 0.5 deaths per 100,000 males in 1982 to 0.2 deaths per 100,000 males in 2020. 

Survival 

In 2014–2018, individuals diagnosed with testicular cancer had a 97% chance of surviving for five years compared to their counterparts in the general Australian population. Between 1989–1993 and 2014–2018, five-year relative survival for testicular cancer improved from 95% to 97%. 

Figure 5. 5-year relative survival for testicular cancer, 1989–1993 to 2014–2018, by sex
Figure 5. 5-year relative survival for testicular cancer, 1989–1993 to 2014–2018, by sex

Notes

Prevalence 

At the end of 2017, there were 882 people living who had been diagnosed with testicular cancer that year, 4,058 people living who had been diagnosed with testicular cancer in the previous 5 years (from 2013 to 2017) and 18,676 people living who had been diagnosed with testicular cancer in the previous 36 years (from 1982 to 2017).

For more information, see Testicular cancer on the NCCI website

The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes.  The NCCI website allows users to see visual representations of data on each indicator through interactive charts.

Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

© 2025 Cancer Australia. All rights reserved.